title: Multiple effects of serotonin and acetylcholine on hyperpolarization-activated inward current in locomotor activity-related neurons in Cfos-EGFP mice.
abstract: Hyperpolarization-activated inward current (I(h)) has been shown to be involved in production of bursting during various forms of rhythmic activity. However, details of I(h) in spinal interneurons related to locomotion remain unknown. Using Cfos-EGFP transgenic mice (P6-P12) we are able to target the spinal interneurons activated by locomotion. Following a locomotor task, whole cell patch-clamp recordings were obtained from ventral EGFP+ neurons in spinal cord slices (T(13)-L(4), 200-250 microm). I(h) was found in 51% of EGFP+ neurons (n = 149) with almost even distribution in lamina VII (51%), VIII (47%), and X (55%). I(h) could be blocked by ZD7288 (10-20 microM) or cesium (1-1.5 mM) but was insensitive to barium (2-2.5 mM). I(h) activated at -80.1 +/- 9.2 mV with half-maximal activation -95.5 +/- 13.3 mV, activation rate 10.0 +/- 3.2 mV, time constant 745 +/- 501 ms, maximal conductance 1.0 +/- 0.7 nS, and reversal potential -34.3 +/- 3.6 mV. 5-HT (15-20 microM) and ACh (20-30 microM) produced variable effects on I(h). 5-HT increased I(h) in 43% of EGFP+ neurons (n = 37), decreased I(h) in 24%, and had no effect on I(h) in 33% of the neurons. ACh decreased I(h) in 67% of EGFP+ neurons (n = 18) with unchanged I(h) in 33% of the neurons. This study characterizes the I(h) in locomotor-related interneurons and is the first to demonstrate the variable effects of 5-HT and ACh on I(h) in rodent spinal interneurons. The finding of 5-HT and ACh-induced reduction of I(h) in EGFP+ neurons suggests a novel mechanism that the motor system could use to limit the participation of certain neurons in locomotion.
authors.affiliation: Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Yue
authors.initials: Y
authors.lastname: Dai
authors.forename: Larry M
authors.initials: LM
authors.lastname: Jordan
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D002586:Cesium / Q000494:pharmacology; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000037:antagonists & inhibitors / Q000502:physiology*; D055724:Electrophysiological Phenomena; D016762:Genes, fos / Q000235:genetics*; D049452:Green Fluorescent Proteins / Q000235:genetics*; D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; D008564:Membrane Potentials / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D009469:Neuromuscular Junction / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000502:physiology*; D011743:Pyrimidines / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology*
chemical_list: D054815:Cyclic Nucleotide-Gated Cation Channels; D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; D015221:Potassium Channels; D011743:Pyrimidines; C485184:enhanced green fluorescent protein; C082246:ICI D2788; D049452:Green Fluorescent Proteins; D002586:Cesium; D012701:Serotonin; D000109:Acetylcholine